Bank of Montreal
SPHS

Bank of Montreal’s Sophiris Bio, Inc. SPHS Stock Holding History

Bank of Montreal’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,000
Closed -$22K – 5023
2018
Q1 		$22K Hold
11,000
– – ﹤0.01% 3540
2017
Q4 		$25K Buy
+11,000
New +$23.9K ﹤0.01% 3524
2017
Q3 		– Sell
-10,400
Closed -$23K – 4492
2017
Q2 		$23K Buy
+10,400
New +$25.5K ﹤0.01% 3500
2017
Q1 		– Sell
-4,100
Closed -$11K – 4381
2016
Q4 		$11K Buy
+4,100
New +$11.6K ﹤0.01% 3587

Other funds holding SPHS

HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
ACM
AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Bank of Montreal's SPHS Position: Q1 2020 in Review

Bank of Montreal sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 1,171 shares.

Bank of Montreal first reported a position in SPHS in Q3 2013 and held it in 25 quarters. The position peaked at $25K in Q4 2017. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Bank of Montreal reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 1,171 Sophiris Bio, Inc. shares in Q1 2020.
  • Bank of Montreal first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 25 quarters.
  • Bank of Montreal's Sophiris Bio, Inc. position peaked at $25K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.